Published in PLoS One on June 18, 2014
The Differentiation of CD4(+) T-Helper Cell Subsets in the Context of Helminth Parasite Infection. Front Immunol (2014) 0.88
PD-1 and its ligands are important immune checkpoints in cancer. Oncotarget (2016) 0.79
Cholera Toxin Promotes Th17 Cell Differentiation by Modulating Expression of Polarizing Cytokines and the Antigen-Presenting Potential of Dendritic Cells. PLoS One (2016) 0.75
RAG-1-deficient mice have no mature B and T lymphocytes. Cell (1992) 20.97
Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol (2010) 11.80
Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol (1998) 11.07
Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu Rev Immunol (1997) 5.95
Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J Exp Med (2007) 5.58
The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model. J Exp Med (1995) 4.21
Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc Natl Acad Sci U S A (1996) 4.11
Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells. J Exp Med (1995) 3.98
Egr-2 and Egr-3 are negative regulators of T cell activation. Nat Immunol (2005) 3.74
Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells. J Exp Med (2008) 3.50
Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. J Immunol (1999) 3.33
An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitro. Proc Natl Acad Sci U S A (1999) 3.15
Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides. J Exp Med (1998) 3.03
CD4 T cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch. J Immunol (2006) 2.99
Interleukin 2 plays a central role in Th2 differentiation. Proc Natl Acad Sci U S A (2004) 2.98
High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy. J Immunol (1999) 2.94
Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction. Immunity (2004) 2.76
IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge. J Immunol (2009) 2.74
Th17 cells are long lived and retain a stem cell-like molecular signature. Immunity (2011) 2.64
Memory CD4+ T cells induce innate responses independently of pathogen. Nat Med (2010) 2.61
Differential expression of interleukin-17A and -17F is coupled to T cell receptor signaling via inducible T cell kinase. Immunity (2009) 2.51
Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity. Blood (2009) 2.33
Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: stat6 is probably not required for the effect of IL-4. J Exp Med (1997) 2.15
High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL. J Immunol (2001) 2.15
Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms. J Clin Invest (2012) 1.95
The effects of IL-6 on CD4 T cell responses. Clin Immunol (2008) 1.90
Evidence implicating utilization of different T cell receptor-associated signaling pathways by TH1 and TH2 clones. J Immunol (1990) 1.84
In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity. J Virol (2000) 1.45
Molecular mechanisms for adaptive tolerance and other T cell anergy models. Semin Immunol (2007) 1.38
The gene related to anergy in lymphocytes, an E3 ubiquitin ligase, is necessary for anergy induction in CD4 T cells. J Immunol (2004) 1.36
Role of TCR-induced extracellular signal-regulated kinase activation in the regulation of early IL-4 expression in naive CD4+ T cells. J Immunol (2003) 1.35
Adaptive tolerance and clonal anergy are distinct biochemical states. J Immunol (2006) 1.32
Peptide requirement for CTL activation reflects the sensitivity to CD3 engagement: correlation with CD8alphabeta versus CD8alphaalpha expression. J Immunol (2001) 1.30
Th17 response and inflammatory autoimmune diseases. Int J Inflam (2011) 1.29
Distinct patterns of membrane microdomain partitioning in Th1 and th2 cells. Immunity (2001) 1.28
Optimal colocalization of TCR and CD8 as a novel mechanism for the control of functional avidity. J Immunol (2002) 1.26
High-avidity CD8+ T cells: optimal soldiers in the war against viruses and tumors. Immunol Res (2005) 1.24
Stat6 and IRS-2 cooperate in interleukin 4 (IL-4)-induced proliferation and differentiation but are dispensable for IL-4-dependent rescue from apoptosis. Mol Cell Biol (2002) 1.21
Low-strength T-cell activation promotes Th17 responses. Blood (2010) 1.15
Anergic Th1 cells express altered levels of the protein tyrosine kinases p56lck and p59fyn. J Immunol (1992) 1.15
Selection of high-avidity CD8 T cells correlates with control of hepatitis C virus infection. Hepatology (2008) 1.14
IL-12 provides proliferation and survival signals to murine CD4+ T cells through phosphatidylinositol 3-kinase/Akt signaling pathway. J Immunol (2002) 1.12
Th1 and Th2 cells form morphologically distinct immunological synapses. J Immunol (2008) 1.08
The TCR-mediated signaling pathways that control the direction of helper T cell differentiation. Semin Immunol (2010) 1.08
Cutting edge: CD8+ T cell clones possess the potential to differentiate into both high- and low-avidity effector cells. J Immunol (2007) 1.06
Early activation signal transduction pathways of Th1 and Th2 cell clones stimulated with anti-CD3. Roles of protein tyrosine kinases in the signal for IL-2 and IL-4 production. J Immunol (1995) 1.03
T cell receptor-induced calcineurin activation regulates T helper type 2 cell development by modifying the interleukin 4 receptor signaling complex. J Exp Med (2000) 1.02
Microbial-induced Th17: superhero or supervillain? J Immunol (2012) 1.02
Selective loss of the calcium ion signaling pathway in T cells maturing toward a T helper 2 phenotype. J Immunol (1997) 1.01
Dose-dependent modulation of CD8 and functional avidity as a result of peptide encounter. Immunology (2007) 1.01
Immunisation route-dependent expression of IL-4/IL-13 can modulate HIV-specific CD8(+) CTL avidity. Eur J Immunol (2009) 0.89
A low antigen dose selectively promotes expansion of high-avidity autoreactive T cells with distinct phenotypic characteristics: a study of human autoreactive CD4+T cells specific for GAD65. Autoimmunity (2010) 0.85